15 Biggest Mid-Day Gainers For Thursday

Prana Biotechnology Limited (ADR) PRAN shares climbed 55.5 percent to $3.86.
Extreme Networks, Inc EXTR shares jumped 21.4 percent to $7.84 after the company announced plans to acquire Brocade's data center networking business for $55 million.
Celyad SA (ADR) CYAD shares gained 21.4 percent to $24.90.
BiondVax Pharmaceuticals Ltd (ADR) BVXV surged 18.9 percent to $6.74 after the company disclosed that it has been approved for a grant from Israel's Ministry of Economy and Industry to build a facility for commercial scale production of its universal flu vaccine candidate M-001.
NQ Mobile Inc (ADR) NQ shares rose 14.4 percent to $4.38 after the company reported a deal to close FL Mobile divestment and for the sale of Showself's live social video business.
Interpace Diagnostics Group Inc IDXG shares climbed 13.7 percent to $2.90. Interpace Diagnostics reported Q4 earnings from continuing operations of $3.25 per share on revenue of $3.122 million.
Acasti Pharma Inc ACST shares rose 13.5 percent to $1.43 after the company announced plans to proceed with Phase 3 CaPRe program following recent end-of-Phase 2 meeting with the FDA.
HTG Molecular Diagnostics Inc HTGM shares gained 13.1 percent to $7.41 after declining 10.27 percent on Wednesday.
AEterna Zentaris Inc. (USA) AEZS shares rose 7.2 percent to $3.11. Aeterna Zentaris disclosed that it intends to file a NDA with respect to Macrilen in the third quarter.
Anthera Pharmaceuticals Inc ANTH gained 6.3 percent to $0.457 after the company reported positive results from the Extension Period of SOLUTION study of Sollpura.
ConocoPhillips COP rose 6 percent to $48.68 after Cenovus Energy agreed to acquire Conocophillips 50 percent interest in FCCL partnership for $17.7 billion. UBS upgraded ConocoPhillips from Neutral to Buy.
Galectin Therapeutics Inc GALT shares gained 5.1 percent to $2.08. H.C. Wainwright upgraded Galectin Therapeutics from Neutral to Buy.
Omeros Corporation OMER rose 4.8 percent to $15.23 after the company reported data in OMS721 Phase 2 trial in renal diseases.
Lindsay Corporation LNN shares rose 3.2 percent to $83.99 after the company posted upbeat quarterly results.
Kingold Jewelry Inc KGJI shares gained 2.6 percent to $1.29. Kingold Jewelry reported Q4 earnings of $0.63 per share on revenue of $357.6 million.